Hua Medicine (Shanghai) (2552.HK) Earnings Analysis
Hua Medicine (Shanghai) (2552.HK) next reports earnings on 2026-08-20, consensus EPS -0.24604 HKD. Trailing P/E 1.96.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 2552.HK next report earnings?
| Next earnings date | 2026-08-20 |
|---|---|
| Consensus EPS estimate | -0.24604 HKD |
| Revenue estimate | 0.58B |
2552.HK earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-08-28 | 1.19 HKD | n/a | n/a | n/a |
| 2024-12-31 | -0.11687 HKD | n/a | n/a | n/a |
| 2024-08-29 | -0.15577 HKD | n/a | n/a | n/a |
2552.HK valuation and analyst view
| Trailing P/E | 1.96 |
|---|---|
| Trailing EPS | 1.048 HKD |
| Price / book | 2.32 |
| Dividend yield | 0.00% |
| Market cap | 2.57B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Hua Medicine (Shanghai) (2552.HK)'s next earnings date?
Hua Medicine (Shanghai) is next scheduled to report on 2026-08-20, with a consensus EPS estimate of -0.24604 HKD and revenue estimate of 0.58B.
Did 2552.HK beat earnings last quarter?
Consensus estimate data was not available for 2552.HK's 2025-08-28 report.
What is 2552.HK's current P/E ratio and EPS?
2552.HK trades at a trailing P/E of 1.96 on trailing EPS of 1.0483705617003394 HKD.
What do analysts rate 2552.HK?
2552.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.